Dr. Elizenda M. Ceballos, MD

Dr. Ceballos practices at Piedmont Eye Center, Inc. in Lynchburg, Virginia.

Dr. Ceballos' NPI, 1558321182, was assigned on March 27, 2006. Dr. Ceballos graduated from Emory School of Medicine in 1996. Dr. Ceballos holds Virginia license 01010230863.

Dr. Ceballos' primary practice is Piedmont Eye Center, Inc., at 116 Nationwide Dr, Lynchburg, VA 24502 in Lynchburg City. The practice phone is (434) 947-3984.

Dr. Ceballos' primary practice is Piedmont Eye Center, Inc. in Lynchburg, Virginia. Dr. Ceballos is also affiliated with Centra Lynchburg General Hospital. Dmand AI also links Dr. Ceballos to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ceballos practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ceballos' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ceballos is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ceballos' licenses on file in 3 states: Virginia, Florida and Georgia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Ceballos treats.

CMS data shows 4,442 Medicare services from Dr. Ceballos across 17 procedure codes in 2024, for 1,240 Medicare patients. Medicare paid $333,990 for them.

CMS counts 1,240 Medicare patients who saw Dr. Ceballos in 2024. The largest group is 75 to 84, with 543 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ceballos' median patient age at 74, with 62% women.

In 2024, Dr. Ceballos wrote 4,363 Medicare Part D claims for 902 patients. 71% of them were for generic drugs. CMS names the drug for 4,286 of them, across 25 drugs with 11 or more claims each, at $356,161 in total drug cost. In 2023, CMS named 4,593 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Ceballos for performance year 2024, reported as part of a group. Dr. Ceballos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 381 procedures of cataract surgery by Dr. Ceballos, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Ceballos. The most frequent topics are Visual Acuity, Intraocular Pressure and Diagnosis, Differential. Dr. Ceballos has published most often in AJNR Am J Neuroradiol. Dr. Ceballos' most frequent co-authors are Richard K. Parrish, MD, Thomas Marshall Aaberg, MD and Donald Lyle Budenz, MD.

CMS Open Payments shows 52 general payments to Dr. Ceballos from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Alcon Laboratories Inc paid the most, $1,269.

Dmand AI lists 1 award for Dr. Ceballos.

Dr. Ceballos graduated from Emory School of Medicine in 1996. Dr. Ceballos is a member of AAO.

Dr. Ceballos is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Molina. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.